Evidence map›Paper›PMID 33778236›Full record

ReviewACS omega2021

Controllable Synthesis of Bimetallic Nanostructures Using Biogenic Reagents: A Green Perspective.

Rufus Mart Ceasar R Ramos, Michelle D Regulacio

Abstract readReview
In one paragraph

Review in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rufus Mart Ceasar R RamosNatural Sciences Research Institute, University of the Philippines Diliman, Quezon City 1101, Philippines.
Michelle D RegulacioNatural Sciences Research Institute, University of the Philippines Diliman, Quezon City 1101, Philippines.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bimetallic nanostructures are emerging as a significant class of metal nanomaterials due to their exceptional properties that are useful in various areas of science and technology. When used for catalysis and sensing applications, bimetallic nanostructures have been noted to exhibit better performance relative to their monometallic counterparts owing to synergistic effects. Furthermore, their dual metal composition and configuration can be modulated to achieve optimal activity for the desired functions. However, as with other nanostructured metals, bimetallic nanostructures are usually prepared through wet chemical routes that involve the use of harsh reducing agents and hazardous stabilizing agents. In response to intensifying concerns over the toxicity of chemicals used in nanomaterial synthesis, the scientific community has increasingly turned its attention toward environmentally and biologically compatible reagents that can enable green and sustainable nanofabrication processes. This article aims to provide an evaluation of the green synthetic methods of constructing bimetallic nanostructures, with emphasis on the use of biogenic resources (e.g., plant extracts, DNA, proteins) as safe and practical reagents. Special attention is devoted to biogenic synthetic protocols that demonstrate controllable nanoscale features, such as size, composition, morphology, and configuration. The potential use of these biogenically prepared bimetallic nanostructures as catalysts and sensors is also discussed. It is hoped that this article will serve as a valuable reference on bimetallic nanostructures and will help fuel new ideas for the development of more eco-friendly strategies for the controllable synthesis of various types of nanostructured bimetallic systems.

Identifiers

PMID33778236
PMCPMC7992060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.